BAX
Baxter International Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$25.83
+1.02%Year over year
Reported trailing growth
- Revenue
- +5.4%
- EBITDA
- -27.5%
- EBIT
- —
- EPS
- —
- Free cash flow
- +103.6%
- Operating cash flow
- +72.4%
Forward estimates
Based on analyst estimates
- Revenue
- +2.2%
- EBITDA
- +214.7%
- EPS
- +203.3%
Three-year CAGR
- Revenue
- +3.8%
- EBITDA
- -33.5%
- EBIT
- —
- Net income
- -47.5%
- EPS
- -37.8%
- Free cash flow
- -17.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026